Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients

Cardiology

Volumn 99, Issue 4, 2003, Pages 205-210

  Shechter, Michael ^a,b   Hod, Hanoch ^a   Rabinowitz, Babeth ^a   Boyko, Valentina ^a   Chouraqui, Pierre ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Clinical trials; Coronary disease; Magnesium; Mortality; Myocardial infarction

Indexed keywords

GLUCOSE; MAGNESIUM SULFATE;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MORTALITY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; VENTRICULAR FUNCTION, LEFT;

EID: 0037634581     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071250     Document Type: Article

References (34)

1. The GUSTO Investigators. GUSTO: An international trial comparing thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
2. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendan J: Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-377.
3. Althouse R, Maynard C, Cerguiera MD, Olsufka M, Ritchie JL, Kennedy JW: The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial. Am J Cardiol 1990;66:1298-1303.
4. Behar S, Abinader E, Caspi A, David D, Flich M, Friedman Y, Hod H, Kaplinsky E, Kishon Y, Kristal N: Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel. Am J Cardiol 1991;68:1291-1294.
5. Behar S, Gilat D, Reicher-Reiss H, Kaplinsky E, Zion M, Mandelzweig L, Goldbourt U: Myocardial infarction in patients older than 75 years of age: The short- and long-term prognosis in 653 consecutive patients. Cardiol Elderly 1993;1:103-111.
6. Shechter M, Kaplinsky E, Rabinowitz B: Review of clinical evidence - is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)? Coron Artery Dis 1996;7:352-358.
7. Antman EM: Randomized trials of magnesium in acute myocardial infarction: Big numbers do not tell the whole story. Am J Cardiol 1995;75:391-393.
8. Seelig MS, Elin RJ: Is there a place for magnesium in the treatment of acute myocardial infarction? Am Heart J 1996;132:471-477.
9. Shechter M, Kaplinsky E, Rabinowitz B: The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Arch Intern Med 1992;152:2189-2196.
10. Woods KL: Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol. 1991;32:3-10.
11. Arsenian MA: Magnesium and cardiovascular disease. Prog Cardiovasc Dis 1993;35:271-310.
12. Horner SM: Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992;86:774-779.
13. Leor J, Kloner RA: An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol. 1995;75:1292-1293.
14. Shechter M, Paul-Labrador MJ, Rude RK, Bairey Merz CN: Intracellular magnesium predicts functional capacity in patients with coronary artery disease. Cardiology 1998;90:168-172.
15. Vormann J, Fiscer G, Classen HG, Thoni H: Influence of decreased and increased magnesium supply on cardiotoxic effects of epinephrine in rats. Arzneimittelforschung 1983;33:205-210.
16. Ravn HB, Vissinger H, Kristensen SD, Husted SE: Magnesium inhibits platelet activity - an in vitro study. Thromb Haemost 1996;76:88-93.
17. Ravn HB, Kristensen SD, Hjortdal VE, Thygesen K, Husted SE: Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol 1997;17:3620-3625.
18. Shechter M, Bairey Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molly MD, Dwyer JH, Shah PK, Kaul S: Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol 1999;84:152-156.
19. Altura BM, Altura BT: New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Magnesium 1985;4:245-271.
20. Dickens BF, Weglicki WB, Li YS, Mark IT: Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS 1992;311:187-191.
21. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE: Magnesium reduces free radicals in a vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 1998;32:536-539.
22. Barros LFM, Chagas ACP, da Luz PL, Pileggi F: Magnesium treatment of acute myocardial infarction: Effects on necrosis in an occlusion/reperfusion dog model. Intern J Cardiol 1995;48:3-9.
23. Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B: Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271-274.
24. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B: Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995;75:321-323.
25. Ferrari R, Albertini A, Curellos S, Ceconi C, Di Lisa F, Raddino R, Visioli O: Myocardial recovery during post-ischemic reperfusion: Effects of nifedipine, calcium, and magnesium. J Moll Cell Cardiol 1986;18:487-498.
26. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE: Magnesium sulfate reduces myocardial infarct size when administered prior to but not after coronary reperfusion in a canine model. Circulation 1995;92:2617-2621.
27. Herzog WR, Scholssberg ML, MacMurdy KS, Edenbaum LR, Gerber MI, Vogel RA, Serebruany VL: Timing of magnesium therapy affects experimental infarct size. Circulation 1995;92:2622-2626.
28. Banai S, Haggroth L, Epstein SE, Casscells W: Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990;67:645-650.
29. Rasmussen HS, Gronbaek M, Cintin C, Balslov S, Norregard P, McNair P: One-year rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988;11:377-381.
30. Woods KL, Fletcher S: Long term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: The Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994;343:816-819.
31. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
32. Antman EM: Magnesium in acute MI. Timing is critical. Circulation 1995;92:2367-2372.
33. Shechter M, Hod H, Kaplinsky E, Rabinowitz B: The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy. Am Heart J 1996;132:483-486.
34. The Magnesium in Coronaries (MAGIC) Trial Investigators: Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: A randomized controlled trial. Lancet 2002;360:1189-1196.